OncoPherese is one type of therapeutic apheresis, which is a common, safe, scientifically valid method of treating various diseases, including multiple sclerosis, lupus, and rheumatic diseases, among others. “Apheresis” comes from the Greek and means “to take away.” OncoPherese is a purely subtractive treatment, meaning nothing is added to the body.
OncoPherese now appears more effective overall at destroying malignant tumors than either chemotherapy or radiation, especially in patients with Stage IV disease – generally accompanied by heavy tumor burden from multiple metastases, extensive prior chemotherapy, and exhaustion of conventional therapeutic options. Extensive testing involving hundred patients has shown it to be both safe and effective.
There are a number of reasons this therapy represents a significant improvement over conventional treatments:
Constant iteration means that the most recent version of OncoPherese technology has the highest efficacy and safety, but also the shortest track record. The only long-term (5+ year) data available is for patients treated with the earliest versions of the technology – which worked well but nowhere near as well as current technology and protocols. One might reasonable ask whether positive outcomes now being observed are likely to persist. Only time will tell for certain, but given the efficacy of this treatment in repeat applications, current results may be sustainable with regular maintenance treatments.
First-time patients should receive a three-week trial of OncoPherese, after which their response is evaluated. If their response has been positive, further treatment can be considered. Some patients require several weeks, even months, of treatment to obtain maximal response. The good news is that patients generally show continued improvement following an initial positive response. This initial evaluation is best accomplished at our facility.
I judge this novel approach for immunotherapy of cancer to be promising and scientifically sound. DR. MED RALF KLEEF, M.D., PH.D.
I am a 56-yr old woman who was diagnosed with Stage IV metastatic breast cancer two years ago. … After OncoPherese treatment, I am now in clinical remission.
When I was diagnosed with an aggressive form of prostate cancer… We decided to proceed with OncoPherese. My PSA, scans and physical findings were normal one month later.
With OncoPherese, [my daughter] has experienced clinical remission twice and no recurrence since April 2008….
The horrible side effects of chemo, radiation and surgery… made my entire family suffer. OncoPherese doesn’t eliminate the stress on the family, but it greatly reduces it. MF
We’re open from 9:00 a.m. to 5:00 p.m. Central European Time (Eastern Standard Time + 6 hours).
From within Germany: +49-8051-909-300
From EU to Germany: +49-8051-909-300
From the U.S.: 011-49-8051-909-300
From within Germany: +49-8051-909-301
From EU to Germany: +49-8051-909-301
From the U.S.: 011-49-8051-909-301